ACB.TO
Canopy Growth Q1 2019 Earnings – The Night is Always Darkest Before the Dawn
Bottom Line: Luckily for Canopy, this was largely a meaningless quarter, because if they put up results like this in…
Tilray Q3 2018 Earnings – Is the Hype Justified?
Bottom Line This was the second quarter we got to see what Tilray is all about and we couldn't find…
Aurora Cannabis Q1 2019 Earnings – A Taste of Things to Come
Bottom Line Though earnings did not include results from early recreational sales, Aurora gave us some clues about how they…
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (October 21, 2018)
The Power of a US Cannabis Listing Bottom Line: A US stock listing has proven to be a hugely positive catalyst…
Aphria to List on NYSE – Pathway to Meaningful Upside Triggered
NYSE Listing Assured Aphria filed a form 40-F with US regulators today to list on the New York Stock Exchange.…
Don’t Underestimate the Power of a US Cannabis Listing
The History of US Cannabis Listings The capital markets for cannabis have really only come into their own in the…
German Firm Seeks Significant Damages from Aurora Cannabis
Germany’s largest independent cannabis distributor has filed a claim for damages against Canadian firm Aurora Cannabis (TSE: ACB) after accusing…
Aphria Q1 2019 Earnings – Warm-Up Quarter, Industry Leading Cost Structure Remains
Bottom Line Aphria's Q1 earnings are a warm-up before the main event — launch of legal recreational in Canada (October…
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (October 6, 2018)
Pepsi Needs Cannabis More than Cannabis Needs Pepsi Bottom Line: When the CFO of Pepsi said the company is not…